[1] |
HOU Xiaoyu, LENG Yufang, CAO Xuefen, LV Xingjiao, HAN Xiaoxia, Janvier NIBARUTA, LIU Yongqiang.
Network analysis and experimental verification of Schisandrin B reduces intestinal ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 147-154.
|
[2] |
HUA Haiyan, YAN Jie, QIN Yufen.
Experimental study of schisandrin B attenuates acute myocardial ischemia injury in rats by inhibiting cardiomyocyte apoptosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 848-856.
|
[3] |
ZHANG Gaojiao, WANG Xinxin, ZHOU Jia, WANG Leilei, DAI Qinxue.
Ginsenoside Rb1 protects brain through Cav-1 for mice with cerebral ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 265-270.
|
[4] |
WU Juan, ZHANG He, FENG Guilin.
Agkistrodon halys venom platelet inhibitor inhibits GPVI expression and changes hemorheology in rats with acute myocardial ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 49-54.
|
[5] |
CHEN Chaohu, ZHUANG Hua, YAO Zhiqiang, HAN Dali, CHANG Cheng, MA Zhongyi, KONG Xiangbing, CAO Jinlong, LI Pan, TIAN Junqiang.
Sodium calcium exchanger and renal ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 355-360.
|
[6] |
SONG Juan, TIAN Xiaoxia, LI Baohong, WANG Dong, MENG Dongchao, LU Yanzhen.
Effect and mechanism of resveratrol alleviates hepatic ischemia reperfusion injury by HMGB1 in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1215-1220.
|
[7] |
FAN Kaiyu,WANG Bing,MEI Xiaole,CHEN Zhiwu.
Protective effects of total flavonoids of Chuzhou chrysanthemum against cerebral ischemia- reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 9-12.
|
[8] |
XU Lin, ZHANG Deng-wen, YANG Shi-jie, TIAN Xue-bi, WANG Yu, HAN Ai-di, ZHANG Chuan-han, TIAN Yu-ke, WANG Xue-ren.
Effect of remote ischemic preconditioning on the expression of myocardial ATP-sensitive potassium channel
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 366-369.
|
[9] |
ZHANG Ya, ZHANG Gen-bao, JI Na, WANG Fei, WU Juan.
Research on the changes of protein C activity in plasma with myocardial ischemia reperfusion injury in rats and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 284-288.
|
[10] |
LIU Ai-hua1, SHI Meng-qiong1, YAN Wen-yan1, YANG Wei-hong1, GONG Xue-qian1, XIONG Yan-qiang1, ZHOU Ji-gang2, LUO Tao2, ZHANG Ji-hong2.
Cardioprotective effect and its mechanism of total saponin from Panacis majoris rhizoma on myocardium ischemia/reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(11): 1224-1232.
|
[11] |
JIAO Chuan-an, SONG Biao, CHEN Zhi-wu.
Effects of exogenous endothelium-dependent hyperpolarizing factor on cerebral ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(6): 648-653.
|
[12] |
MAO Chao-ming, CHEN Hui-le, WANG Wan-tie, JIN Ke-ke, QIU Xiao-xiao, XIE Ke-jian.
Regulatory effect of ligustrazine on the dynamic change of thromboxane/prostacyclin in renal ischemia reperfusion injury rabbits
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(6): 637-641.
|
[13] |
GAO Cong , PENG Fei-cheng ,QIAN Zhi-yu.
Protective effects of crocetin on cerebral ischemia-reperfusion injury in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(4): 421-425.
|
[14] |
YUAN Heng-Jie, , LUO Qiong, ZHU Xue-hui, YU Pei, LI Yu-mei, WU Yan-na, KANG Yi, JIAO Jian-jie, LOU Jian-shi.
Protection of noninvasive delayed limb ischemic preconditioning on cortex against cerebral ischemia reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(2): 144-149.
|
[15] |
QIN Yan-wen, YE Ping, WANG Lu-ya, YANG Ya.
Primary prevention effect of atorvastatin on myocardial hypertrophy in ApoE-deficient (ApoE-/-) mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 48-51.
|